{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T08:30:09Z","timestamp":1793694609604,"version":"4.5.1"},"reference-count":47,"publisher":"American Association for Cancer Research (AACR)","issue":"6","funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K08CA248940"],"award-info":[{"award-number":["K08CA248940"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K08CA241076"],"award-info":[{"award-number":["K08CA241076"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K08CA267307"],"award-info":[{"award-number":["K08CA267307"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014549","name":"Stanford Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014549","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32 HL120824"],"award-info":[{"award-number":["T32 HL120824"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001422","name":"American Society of Hematology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001422","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,11,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>Relapsed and\/or refractory disease remains the leading cause of death in acute myeloid leukemia (AML), highlighting the need for broadly applicable, high-sensitivity approaches to measurable residual disease (MRD) detection. We developed AML-Cancer Personalized Profiling by Deep Sequencing (CAPP-Seq), a personalized hybrid-capture assay that tracks both canonical AML drivers and patient-specific variants identified by whole-exome sequencing. In 56 patients with longitudinal plasma and matched peripheral blood and bone marrow samples, AML-CAPP-Seq enabled universal MRD assessment and resolution of clonal dynamics using a median of 30.5 variants per patient. Plasma circulating tumor DNA (ctDNA) outperformed cellular compartments for MRD detection and more strongly predicted relapse-free survival [hazard ratio (HR), 17.8; P &amp;lt; 0.0001] and overall survival (HR, 17; P &amp;lt; 0.0001) than standard-of-care (SOC) MRD methods. Among 29 allogeneic transplant recipients, peritransplant ctDNA-MRD dynamics markedly improved relapse risk stratification (HR, 36; P = 0.0009). Together, these results establish personalized ctDNA profiling as a minimally invasive, highly sensitive, and generalizable platform for enhanced clinical MRD detection and clonal surveillance in AML.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>We present a personalized blood test for AML that tracks patient-specific ctDNA, enabling sensitive, universal, and noninvasive detection of residual disease. It outperforms SOC marrow- and cell-based methods for predicting relapse and survival, including after transplant, reveals clonal dynamics, and supports individualized disease monitoring and risk-adapted treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/2643-3230.bcd-26-0159","type":"journal-article","created":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T19:49:07Z","timestamp":1786477747000},"page":"921-939","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Personalized Circulating Tumor DNA Profiling Enables Superior and Universal Residual Disease Detection in Acute Myeloid Leukemia"],"prefix":"10.1158","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-9798-4922","authenticated-orcid":false,"given":"Ruwan","family":"Gunaratne","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00f54p054","id-type":"ROR","asserted-by":"publisher"}],"name":"Stanford University 1 Division of Hematology, Department of Medicine, , Stanford, California."},{"id":[{"id":"https:\/\/ror.org\/00f54p054","id-type":"ROR","asserted-by":"publisher"}],"name":"Stanford University 2 Stanford Cancer Institute, , Stanford, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-7957-9427","authenticated-orcid":false,"given":"Crystal M.","family":"Zhou","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00f54p054","id-type":"ROR","asserted-by":"publisher"}],"name":"Stanford University 1 Division of Hematology, Department of Medicine, , Stanford, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9336-422X","authenticated-orcid":false,"given":"Sanjeeth","family":"Rajaram","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00f54p054","id-type":"ROR","asserted-by":"publisher"}],"name":"Stanford University 1 Division of Hematology, Department of Medicine, , Stanford, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6556-4171","authenticated-orcid":false,"given":"Jesse W.","family":"Tai","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00f54p054","id-type":"ROR","asserted-by":"publisher"}],"name":"Stanford University 1 Division of Hematology, Department of Medicine, , Stanford, California."},{"id":[{"id":"https:\/\/ror.org\/00f54p054","id-type":"ROR","asserted-by":"publisher"}],"name":"Stanford University 2 Stanford Cancer Institute, , Stanford, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-4946-3687","authenticated-orcid":false,"given":"Kailee L.","family":"Tanaka","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00f54p054","id-type":"ROR","asserted-by":"publisher"}],"name":"Stanford University 1 Division of Hematology, Department of Medicine, , Stanford, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-1605-5038","authenticated-orcid":false,"given":"Charu","family":"Tiwari","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00f54p054","id-type":"ROR","asserted-by":"publisher"}],"name":"Stanford University 1 Division of Hematology, Department of Medicine, , Stanford, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6028-2455","authenticated-orcid":false,"given":"Emily Y.","family":"Yang","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00f54p054","id-type":"ROR","asserted-by":"publisher"}],"name":"Stanford University 1 Division of Hematology, Department of Medicine, , Stanford, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-8550-9019","authenticated-orcid":false,"given":"Sky","family":"Kim","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00f54p054","id-type":"ROR","asserted-by":"publisher"}],"name":"Stanford University 3 Department of Medicine, , Stanford, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-0113-5116","authenticated-orcid":false,"given":"Grace","family":"Gao","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00f54p054","id-type":"ROR","asserted-by":"publisher"}],"name":"Stanford University 1 Division of Hematology, Department of Medicine, , Stanford, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8180-9968","authenticated-orcid":false,"given":"Raymond","family":"Yin","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/043mz5j54","id-type":"ROR","asserted-by":"publisher"}],"name":"University of California San Francisco 4 Department of Medicine, , San Francisco, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9993-9787","authenticated-orcid":false,"given":"Mia","family":"Carleton","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00f54p054","id-type":"ROR","asserted-by":"publisher"}],"name":"Stanford University 5 Division of Oncology, Department of Medicine, , Stanford, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4193-8180","authenticated-orcid":false,"given":"Matthew S.","family":"Alkaitis","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00f54p054","id-type":"ROR","asserted-by":"publisher"}],"name":"Stanford University 3 Department of Medicine, , Stanford, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0778-9230","authenticated-orcid":false,"given":"Matthew","family":"Schwede","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/004jktf35","id-type":"ROR","asserted-by":"publisher"}],"name":"Swedish Medical Center 6 Center for Blood Disorders and Stem Cell Transplantation, , Seattle, Washington."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5902-5507","authenticated-orcid":false,"given":"Brian J.","family":"Sworder","sequence":"additional","affiliation":[{"name":"7Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, California."},{"name":"8Department of Molecular Diagnostics and Experimental Therapeutics, City of Hope National Medical Center, Duarte, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-8202-0870","authenticated-orcid":false,"given":"Gabriel N.","family":"Mannis","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00f54p054","id-type":"ROR","asserted-by":"publisher"}],"name":"Stanford University 1 Division of Hematology, Department of Medicine, , Stanford, California."},{"id":[{"id":"https:\/\/ror.org\/00f54p054","id-type":"ROR","asserted-by":"publisher"}],"name":"Stanford University 2 Stanford Cancer Institute, , Stanford, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9061-7351","authenticated-orcid":false,"given":"Michael S.","family":"Khodadoust","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00f54p054","id-type":"ROR","asserted-by":"publisher"}],"name":"Stanford University 2 Stanford Cancer Institute, , Stanford, California."},{"id":[{"id":"https:\/\/ror.org\/00f54p054","id-type":"ROR","asserted-by":"publisher"}],"name":"Stanford University 5 Division of Oncology, Department of Medicine, , Stanford, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5814-0984","authenticated-orcid":false,"given":"Ravindra","family":"Majeti","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00f54p054","id-type":"ROR","asserted-by":"publisher"}],"name":"Stanford University 1 Division of Hematology, Department of Medicine, , Stanford, California."},{"id":[{"id":"https:\/\/ror.org\/00f54p054","id-type":"ROR","asserted-by":"publisher"}],"name":"Stanford University 2 Stanford Cancer Institute, , Stanford, California."},{"id":[{"id":"https:\/\/ror.org\/00f54p054","id-type":"ROR","asserted-by":"publisher"}],"name":"Stanford University 9 Stanford Institute for Stem Cell Biology and Regenerative Medicine, , Stanford, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6382-4651","authenticated-orcid":false,"given":"David M.","family":"Kurtz","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00f54p054","id-type":"ROR","asserted-by":"publisher"}],"name":"Stanford University 2 Stanford Cancer Institute, , Stanford, California."},{"id":[{"id":"https:\/\/ror.org\/00f54p054","id-type":"ROR","asserted-by":"publisher"}],"name":"Stanford University 5 Division of Oncology, Department of Medicine, , Stanford, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6274-0763","authenticated-orcid":false,"given":"Tian Yi","family":"Zhang","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00f54p054","id-type":"ROR","asserted-by":"publisher"}],"name":"Stanford University 1 Division of Hematology, Department of Medicine, , Stanford, California."},{"id":[{"id":"https:\/\/ror.org\/00f54p054","id-type":"ROR","asserted-by":"publisher"}],"name":"Stanford University 2 Stanford Cancer Institute, , Stanford, California."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2026,8,11]]},"reference":[{"key":"2026110303160965700_bib1","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1056\/nejmra1406184","article-title":"Acute myeloid leukemia","volume":"373","author":"Dohner","year":"2015","journal-title":"N Engl J Med"},{"key":"2026110303160965700_bib2","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1056\/NEJMoa1301689","article-title":"Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia","volume":"368","author":"Cancer Genome Atlas Research Network","year":"2013","journal-title":"N Engl J Med"},{"key":"2026110303160965700_bib3","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1056\/NEJMoa1516192","article-title":"Genomic classification and prognosis in acute myeloid leukemia","volume":"374","author":"Papaemmanuil","year":"2016","journal-title":"N Engl J Med"},{"key":"2026110303160965700_bib4","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1002\/ajh.25214","article-title":"Acute myeloid leukemia: 2019 update on risk-stratification and management","volume":"93","author":"Estey","year":"2018","journal-title":"Am J Hematol"},{"key":"2026110303160965700_bib5","doi-asserted-by":"publisher","first-page":"359","DOI":"10.3390\/biomedicines11020359","article-title":"Measurable residual disease and clonal evolution in acute myeloid leukemia from diagnosis to post-transplant follow-up: the role of next-generation sequencing","volume":"11","author":"Sperotto","year":"2023","journal-title":"Biomedicines"},{"key":"2026110303160965700_bib6","doi-asserted-by":"publisher","first-page":"2810","DOI":"10.3324\/haematol.2022.282034","article-title":"The present and future of measurable residual disease testing in acute myeloid leukemia","volume":"107","author":"Blachly","year":"2022","journal-title":"Haematologica"},{"key":"2026110303160965700_bib7","doi-asserted-by":"publisher","first-page":"603636","DOI":"10.3389\/fonc.2020.603636","article-title":"MRD tailored therapy in AML: what we have learned so far","volume":"10","author":"Ngai","year":"2020","journal-title":"Front Oncol"},{"key":"2026110303160965700_bib8","doi-asserted-by":"publisher","first-page":"2753","DOI":"10.1182\/blood.2021013626","article-title":"2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party","volume":"138","author":"Heuser","year":"2021","journal-title":"Blood"},{"key":"2026110303160965700_bib9","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1038\/s41698-025-00876-y","article-title":"Circulating tumor DNA to monitor treatment response in solid tumors and advance precision oncology","volume":"9","author":"Bartolomucci","year":"2025","journal-title":"NPJ Precis Oncol"},{"key":"2026110303160965700_bib10","doi-asserted-by":"publisher","first-page":"2968","DOI":"10.1158\/2159-8290.CD-21-0634","article-title":"Detecting liquid remnants of solid tumors: circulating tumor DNA minimal residual disease","volume":"11","author":"Moding","year":"2021","journal-title":"Cancer Discov"},{"key":"2026110303160965700_bib11","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/nbt.3520","article-title":"Integrated digital error suppression for improved detection of circulating tumor DNA","volume":"34","author":"Newman","year":"2016","journal-title":"Nat Biotechnol"},{"key":"2026110303160965700_bib12","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1038\/nm.3519","article-title":"An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage","volume":"20","author":"Newman","year":"2014","journal-title":"Nat Med"},{"key":"2026110303160965700_bib13","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/s41586-018-0623-z","article-title":"Functional genomic landscape of acute myeloid leukaemia","volume":"562","author":"Tyner","year":"2018","journal-title":"Nature"},{"key":"2026110303160965700_bib14","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1126\/science.1235122","article-title":"Cancer genome landscapes","volume":"339","author":"Vogelstein","year":"2013","journal-title":"Science"},{"key":"2026110303160965700_bib15","first-page":"641","article-title":"Machine learning predictability of clinical next generation sequencing for hematologic malignancies to guide high-value precision medicine","volume":"2021","author":"Kim","year":"2021","journal-title":"AMIA Annu Symp Proc"},{"key":"2026110303160965700_bib16","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1158\/2159-8290.CD-17-0716","article-title":"Early detection of molecular residual disease in localized lung cancer by circulating tumor DNA profiling","volume":"7","author":"Chaudhuri","year":"2017","journal-title":"Cancer Discov"},{"key":"2026110303160965700_bib17","doi-asserted-by":"publisher","first-page":"106971","DOI":"10.1016\/j.leukres.2022.106971","article-title":"Measurable residual disease by flow cytometry in acute myeloid leukemia is prognostic, independent of genomic profiling","volume":"123","author":"Ganzel","year":"2022","journal-title":"Leuk Res"},{"key":"2026110303160965700_bib18","doi-asserted-by":"publisher","first-page":"77 e1","DOI":"10.1016\/j.jtct.2024.11.006","article-title":"Early mixed donor chimerism is a strong negative prognostic indicator in allogeneic stem cell transplant for AML and MDS","volume":"31","author":"Radford","year":"2025","journal-title":"Transpl Cell Ther"},{"key":"2026110303160965700_bib19","doi-asserted-by":"publisher","first-page":"3666","DOI":"10.1182\/bloodadvances.2022009493","article-title":"Posttransplant MRD and T-cell chimerism status predict outcomes in patients who received allografts for AML\/MDS","volume":"7","author":"Loke","year":"2023","journal-title":"Blood Adv"},{"key":"2026110303160965700_bib20","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1159\/000516793","article-title":"The prognostic ability of RAS pathway-related gene mutations in patients with myeloid neoplasms treated with hypomethylating agents","volume":"144","author":"Park","year":"2021","journal-title":"Acta Haematol"},{"key":"2026110303160965700_bib21","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1182\/bloodadvances.2023011757","article-title":"Prognostic risk signature in patients with acute myeloid leukemia treated with hypomethylating agents and venetoclax","volume":"8","author":"Bataller","year":"2024","journal-title":"Blood Adv"},{"key":"2026110303160965700_bib22","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/s41586-024-08137-x","article-title":"RAS-mutant leukaemia stem cells drive clinical resistance to venetoclax","volume":"636","author":"Sango","year":"2024","journal-title":"Nature"},{"key":"2026110303160965700_bib23","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1182\/bloodadvances.2021006242","article-title":"Molecular, clinical, and prognostic implications of PTPN11 mutations in acute myeloid leukemia","volume":"6","author":"Fobare","year":"2022","journal-title":"Blood Adv"},{"key":"2026110303160965700_bib24","doi-asserted-by":"publisher","first-page":"5429","DOI":"10.1200\/JCO.2008.16.0333","article-title":"Mutation of the Wilms\u2019 tumor 1 gene is a poor prognostic factor associated with chemotherapy resistance in normal karyotype acute myeloid leukemia: the United Kingdom Medical Research Council Adult Leukaemia Working Party","volume":"26","author":"Virappane","year":"2008","journal-title":"J Clin Oncol"},{"key":"2026110303160965700_bib25","doi-asserted-by":"publisher","first-page":"2536","DOI":"10.1038\/s41375-018-0147-4","article-title":"NF1 mutations are recurrent in adult acute myeloid leukemia and confer poor outcome","volume":"32","author":"Eisfeld","year":"2018","journal-title":"Leukemia"},{"key":"2026110303160965700_bib26","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/nmeth.2883","article-title":"PyClone: statistical inference of clonal population structure in cancer","volume":"11","author":"Roth","year":"2014","journal-title":"Nat Methods"},{"key":"2026110303160965700_bib27","doi-asserted-by":"publisher","first-page":"e1003665","DOI":"10.1371\/journal.pcbi.1003665","article-title":"SciClone: inferring clonal architecture and tracking the spatial and temporal patterns of tumor evolution","volume":"10","author":"Miller","year":"2014","journal-title":"PLoS Comput Biol"},{"key":"2026110303160965700_bib28","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1182\/blood.2024025154","article-title":"Measurable residual disease and posttransplantation gilteritinib maintenance for patients with FLT3-ITD-mutated AML","volume":"145","author":"Levis","year":"2025","journal-title":"Blood"},{"key":"2026110303160965700_bib29","first-page":"129","volume-title":"Acute myeloid leukemia-use of measurable residual disease to improve outcomes. Advances in experimental medicine and biology","author":"Tettero","year":"2025"},{"key":"2026110303160965700_bib30","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/nature22993","article-title":"Tracing the origins of relapse in acute myeloid leukaemia to stem cells","volume":"547","author":"Shlush","year":"2017","journal-title":"Nature"},{"key":"2026110303160965700_bib31","doi-asserted-by":"publisher","first-page":"5327","DOI":"10.1038\/s41467-020-19119-8","article-title":"Clonal evolution of acute myeloid leukemia revealed by high-throughput single-cell genomics","volume":"11","author":"Morita","year":"2020","journal-title":"Nat Commun"},{"key":"2026110303160965700_bib32","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1182\/blood.2024027948","article-title":"Rapid clonal selection within early hematopoietic cell compartments presages the outcome of ivosidenib combination therapy","volume":"147","author":"Turkalj","year":"2026","journal-title":"Blood"},{"key":"2026110303160965700_bib33","doi-asserted-by":"publisher","first-page":"116236","DOI":"10.1016\/j.celrep.2025.116236","article-title":"A single-cell framework identifies functionally and molecularly distinct multipotent progenitors in adult human hematopoiesis","volume":"44","author":"Ediriwickrema","year":"2025","journal-title":"Cell Rep"},{"key":"2026110303160965700_bib34","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1182\/blood.2023021579","article-title":"Molecular MRD is strongly prognostic in patients with NPM1-mutated AML receiving venetoclax-based nonintensive therapy","volume":"143","author":"Othman","year":"2024","journal-title":"Blood"},{"key":"2026110303160965700_bib35","doi-asserted-by":"publisher","first-page":"e70286","DOI":"10.1002\/cncr.70286","article-title":"Minimal residual disease in solid tumors: clinical applications and future directions","volume":"132","author":"Abdo","year":"2026","journal-title":"Cancer"},{"key":"2026110303160965700_bib36","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1007\/s40291-021-00559-x","article-title":"Commercial ctDNA assays for minimal residual disease detection of solid tumors","volume":"25","author":"Chen","year":"2021","journal-title":"Mol Diagn Ther"},{"key":"2026110303160965700_bib37","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/s41586-020-2140-0","article-title":"Integrating genomic features for non-invasive early lung cancer detection","volume":"580","author":"Chabon","year":"2020","journal-title":"Nature"},{"key":"2026110303160965700_bib38","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1038\/s41467-025-56486-6","article-title":"Deciphering response dynamics and treatment resistance from circulating tumor DNA after CAR T-cells in multiple myeloma","volume":"16","author":"Hosoya","year":"2025","journal-title":"Nat Commun"},{"key":"2026110303160965700_bib39","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/ng.2892","article-title":"A general framework for estimating the relative pathogenicity of human genetic variants","volume":"46","author":"Kircher","year":"2014","journal-title":"Nat Genet"},{"key":"2026110303160965700_bib40","doi-asserted-by":"publisher","first-page":"D886","DOI":"10.1093\/nar\/gky1016","article-title":"CADD: predicting the deleteriousness of variants throughout the human genome","volume":"47","author":"Rentzsch","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"2026110303160965700_bib41","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1101\/gr.3715005","article-title":"Evolutionarily conserved elements in vertebrate, insect, worm, and yeast genomes","volume":"15","author":"Siepel","year":"2005","journal-title":"Genome Res"},{"key":"2026110303160965700_bib42","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1038\/s41586-020-2876-6","article-title":"A comparative genomics multitool for scientific discovery and conservation","volume":"587","author":"Zoonomia","year":"2020","journal-title":"Nature"},{"key":"2026110303160965700_bib43","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1101\/gr.176601","article-title":"Predicting deleterious amino acid substitutions","volume":"11","author":"Ng","year":"2001","journal-title":"Genome Res"},{"key":"2026110303160965700_bib44","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1126\/science.ade2574","article-title":"Evolutionary-scale prediction of atomic-level protein structure with a language model","volume":"379","author":"Lin","year":"2023","journal-title":"Science"},{"key":"2026110303160965700_bib45","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12859-017-1996-y","article-title":"diceR: an R package for class discovery using an ensemble driven approach","volume":"19","author":"Chiu","year":"2018","journal-title":"BMC Bioinformatics"},{"key":"2026110303160965700_bib46","doi-asserted-by":"publisher","first-page":"3076","DOI":"10.1093\/annonc\/mdx517","article-title":"ClonEvol: clonal ordering and visualization in cancer sequencing","volume":"28","author":"Dang","year":"2017","journal-title":"Ann Oncol"},{"key":"2026110303160965700_bib47","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1186\/s12864-016-3195-z","article-title":"Visualizing tumor evolution with the fishplot package for R","volume":"17","author":"Miller","year":"2016","journal-title":"BMC Genomics"}],"container-title":["Blood Cancer Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/bloodcancerdiscov\/article-pdf\/doi\/10.1158\/2643-3230.BCD-26-0159\/3820820\/bcd-26-0159.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/bloodcancerdiscov\/article-pdf\/doi\/10.1158\/2643-3230.BCD-26-0159\/3836408\/bcd-26-0159.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/bloodcancerdiscov\/article-pdf\/7\/6\/921\/3844133\/bcd-26-0159.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/bloodcancerdiscov\/article-pdf\/7\/6\/921\/3844133\/bcd-26-0159.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T08:16:18Z","timestamp":1793693778000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/bloodcancerdiscov\/article\/7\/6\/921\/789632\/Personalized-Circulating-Tumor-DNA-Profiling"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,11]]},"references-count":47,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,8,11]]},"published-print":{"date-parts":[[2026,11,3]]}},"URL":"https:\/\/doi.org\/10.1158\/2643-3230.bcd-26-0159","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/2643-3230.34897973","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.34897961","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.34897892","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.34897937","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.34897925","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.34897913","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.34897967","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.34897901","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.34897955","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.34897943","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.34897931","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.34897898","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.34897928","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.34897916","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.34897940","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.34897895","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.34897970","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.34897904","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.34897958","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.34897946","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.34897934","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.34897922","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.34897910","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.34897964","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.34897952","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.34897919","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.34897907","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.34897949","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/2643-3230.c.8814734","asserted-by":"object"}]},"ISSN":["2643-3230","2643-3249"],"issn-type":[{"value":"2643-3230","type":"print"},{"value":"2643-3249","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,11]]}}}